Dune Medical Devices
Dune Medical Devices is a privately held medical device company founded in 2002 and based in Atlanta that develops intraoperative, real-time cancer detection devices for surgical oncology, serving hospitals and breast cancer surgeons with proprietary tissue characterization technology.
- Company typePrivate
- Founded2002
- HeadquartersAtlanta, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dune Medical Devices does
Dune Medical Devices is a privately held medical device company founded in 2002 and headquartered in Atlanta, United States. The company develops intraoperative, real-time cancer detection devices for surgical oncology, with an apparent focus on supporting surgeons during tumor resection procedures (such as breast cancer surgery) by providing tissue characterization feedback at the point of surgery. The company operates in a regulated Class II/III medical device category and has maintained a dedicated VP of Clinical & Regulatory Affairs role, indicating ongoing FDA engagement and likely existing 510(k) or PMA clearances.
The company has raised approximately $50M across six funding rounds from 2004 to 2017, drawing capital from institutional healthcare investors including Apax Partners, ATON Partners, Evidity Health Capital, The Kraft Group, and Boston MedTech Advisors. It also received non-dilutive funding from EISMEA (European Innovation Council) in 2017, suggesting European market expansion activity. Headcount is reported at 11-50 employees.
The leadership team includes a Chairman, CFO, VP of R&D, VP of Clinical & Regulatory Affairs, and a notably dedicated VP of Healthcare Economics & Reimbursement — a role that indicates active commercialization, hospital sales cycles, and payer reimbursement strategy rather than purely pre-commercial R&D. The business model appears to follow the standard specialty medical device playbook: regulatory-cleared capital equipment or disposable probe-based device sold to hospital systems and breast surgery centers, with reimbursement pursued via CPT codes and payer coverage decisions.
Dune Medical Devices firmographics
Firmographics- Name
- Dune Medical Devices
- Website
- https://dunemedical.com
- Company type
- Private
- Founded year
- 2002
- Headcount range
- 11–50 employees
- Short description
- Dune Medical Devices is a privately held medical device company founded in 2002 and based in Atlanta that develops intraoperative, real-time cancer detection devices for surgical oncology, serving hospitals and breast cancer surgeons with proprietary tissue characterization technology.
- Ownership category
- akta.pro rank
Dune Medical Devices industry classification
Industry- Product category
- Surgical Oncology Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Surgical Oncology (HLAKAFAG)
- akta.pro secondary industry
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
Keywords
Where Dune Medical Devices is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Markets served
Dune Medical Devices business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Dune Medical Devices product offering
Product offeringCore offering
Dune Medical Devices develops and commercializes intraoperative, real-time cancer detection devices used during surgical oncology procedures. The company's technology is designed to help surgeons identify cancerous tissue at the margins of a resection in real time, supporting more complete tumor removal during surgery. The firm operates as a medical device manufacturer targeting clinical and hospital customers.
Product overview
No substantive product information available in the provided source data. The source only contains a tracking pixel reference and a privacy notice link from dunemedical.com without any details about the company's products, services, or technology offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Intraoperative Real-Time Cancer Detection Device
Companies that use Dune Medical Devices
Customer profileIdeal customer profiles1 record
Dune Medical Devices technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Dune Medical Devices partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights4 records
Dune Medical Devices competitors and assessment
Company assessmentDirect peers
- Lumicell: Lumicell develops real-time intraoperative molecular imaging systems (e.g., LUM015) to detect residual cancer tissue during breast and other oncology surgeries, making it the closest direct competitor to Dune Medical's intraoperative cancer detection platform.
- Perimeter Medical Imaging: Perimeter Medical Imaging (now part of Sencure) develops wide-field optical coherence tomography (OCT) imaging for intraoperative margin assessment in breast-conserving surgery — directly addressing the same clinical workflow as Dune's cancer detection device.
- Lightpoint Medical: Lightpoint Medical develops intraoperative molecular imaging and sensing technologies (e.g., Cerenkov luminescence) for cancer surgery, targeting the same intraoperative oncology detection use case as Dune Medical Devices.
Broad incumbents
- Hologic: Hologic is a large women's health and diagnostics incumbent with breast surgery and biopsy products (including the Faxitron specimen radiography line), serving as a broad incumbent in breast cancer surgical workflows where Dune's detection device is used.
- Medtronic: Medtronic operates across surgical oncology with energy devices, navigation systems, and intraoperative tools, making it a broad incumbent that competes for hospital budgets and OR workflow integration with niche players like Dune.
- Intuitive Surgical: Intuitive Surgical's da Vinci platform dominates robotic-assisted oncology surgery and increasingly integrates intraoperative imaging and detection — a broad incumbent whose ecosystem could either enable or threaten niche intraoperative detection devices.
- Carl Zeiss Meditec: ZEISS Meditec provides surgical microscopy and intraoperative visualization used in oncology and neurosurgery, serving as a broad incumbent in image-guided and intraoperative cancer surgery workflows adjacent to Dune's product.
- Stryker: Stryker's surgical instruments, navigation, and fluorescence imaging (e.g., SPY-PHI) compete for intraoperative oncology workflows, putting it in the broad incumbent category relative to Dune's intraoperative cancer detection niche.
Emerging players
- Novadaq Technologies (acquired by Stryker): Novadaq's fluorescence imaging platform (SPY) for intraoperative perfusion and tissue assessment was acquired by Stryker; it represents the type of emerging intraoperative imaging technology that overlaps with Dune's intraoperative cancer detection value proposition.
- Angle plc: Angle plc's Parsortix CTC platform enables liquid biopsy-based cancer detection; while not an intraoperative device, it addresses the same overarching cancer detection market that Dune targets with its intraoperative approach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Dune Medical Devices social profiles
Digital presenceDune Medical Devices financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dune Medical Devices leadership team
Management profileNumber of profiles
Profiles5 records
Dune Medical Devices funding detail
Funding detailFunding overview
Funding rounds6 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dune Medical Devices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dune Medical Devices
What does Dune Medical Devices do?
Dune Medical Devices develops and commercializes intraoperative, real-time cancer detection devices used during surgical oncology procedures. The company's technology is designed to help surgeons identify cancerous tissue at the margins of a resection in real time, supporting more complete tumor removal during surgery. The firm operates as a medical device manufacturer targeting clinical and hospital customers.
When was Dune Medical Devices founded?
Dune Medical Devices was founded in 2002. It employs 11 to 50 people.
Where is Dune Medical Devices based?
Dune Medical Devices is headquartered in Atlanta, United States, in the North America region.
Who are Dune Medical Devices's main competitors?
Direct peers on record are Lumicell, Perimeter Medical Imaging and Lightpoint Medical. Broad incumbents are Hologic, Medtronic, Intuitive Surgical, Carl Zeiss Meditec and Stryker. Emerging players are Novadaq Technologies (acquired by Stryker) and Angle plc.
Does Dune Medical Devices have an API?
No public API is recorded for Dune Medical Devices.
What industry is Dune Medical Devices in?
Dune Medical Devices's product category is Surgical Oncology Devices. Its primary akta.pro industry code is HLAKAFAG, Surgical Oncology, with a secondary code of HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 339112 and its SIC code is 3841.